Cure8

Why This Matters

A new CE-marked food-intolerance diagnostic could give people with Crohn’s or UC a non-invasive tool to explore dietary triggers alongside clinical care. Regulatory certification means the products met EU safety and performance rules, which may increase availability in Europe.

Who Should Pay Attention

Patients with Crohn’s disease or ulcerative colitis interested in diet-based testing, clinicians who manage IBD, and patient advocates following diagnostic test availability and regulatory clearances.

Study Snapshot

Story typeBusiness news
Evidence typeRegulatory update
Source depthFull source text

What To Know

Biomerica announced EU IVDR (CE-marking) certification for its food intolerance diagnostic products aimed at people with Crohn’s disease and ulcerative colitis. The company says the tests use proprietary technology to identify foods that may trigger inflammation and plans near-term product launch/market expansion in Europe.

Keep In Mind

This is a company press release about regulatory certification (IVDR/CE mark) and planned commercial launch. The announcement does not provide independent clinical data in the text, nor details on diagnostic accuracy, how results should be used clinically, or guideline endorsement. People should discuss any test results with their care team before changing treatment or diet.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Regulatory update Article type assigned from Cure8 classification; confirm details in the original source.
Publicationfinance.yahoo.com
Indexed viaBing News
Source typeBusiness news
PublishedFeb 26, 2025, 5:19 AM
Content availableFull source text

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →